Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term efmoroctocog alfa prophylaxis improves perceived pain, mental, and physical health in patients with hemophilia A: post hoc analysis of phase III trials using patient-reported outcomes.
Raheja P, Kragh N, Bystrická L, Eriksson D, Aroui K, Mezghani M, Barbier S, Linari S. Raheja P, et al. Among authors: barbier s. Ther Adv Hematol. 2024 Jul 30;15:20406207241257917. doi: 10.1177/20406207241257917. eCollection 2024. Ther Adv Hematol. 2024. PMID: 39091324 Free PMC article.
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B: post hoc analysis of phase III trials using patient-reported outcomes.
Astermark J, Hermans C, Ezzalfani M, Sidhom A, Barbier S, Kragh N, Falk A, Eriksson D. Astermark J, et al. Among authors: barbier s. Ther Adv Hematol. 2023 May 29;14:20406207231170701. doi: 10.1177/20406207231170701. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37283819 Free PMC article.
Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson's Disease.
Epping-Jordan MP, Girard F, Bessis AS, Mutel V, Boléa C, Derouet F, Bessif A, Mingard B, Barbier S, Paradis JS, Rocher JP, Lütjens R, Kalinichev M, Poli S. Epping-Jordan MP, et al. Among authors: barbier s. Cells. 2023 Mar 24;12(7):1004. doi: 10.3390/cells12071004. Cells. 2023. PMID: 37048075 Free PMC article.
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.
Barbier S, Beaufils B, de Miguel R, Reyre M, Le Meitour Y, Lortie A, de Boisferon MH, Chaumeron S, Espirito A, Fossati L, Lagarde P, Klinz S, Thiagalingam A, Lezmi S, Meyer-Losic F. Barbier S, et al. Oncol Ther. 2023 Mar;11(1):111-128. doi: 10.1007/s40487-022-00215-2. Epub 2023 Jan 16. Oncol Ther. 2023. PMID: 36645622 Free PMC article.
Rationale and Purpose: The FLUTE Study to Evaluate Fluorography Mass Screening for Tuberculosis and Other Diseases, as Conducted in Eastern Europe and Central Asia Countries.
Smelov V, Trusova O, Barbier S, Muwonge R, Grankov V, Rusovich V, Baena A, Gaffield ML, Corbex MA, Dara M. Smelov V, et al. Among authors: barbier s. Int J Environ Res Public Health. 2022 Jul 17;19(14):8706. doi: 10.3390/ijerph19148706. Int J Environ Res Public Health. 2022. PMID: 35886558 Free PMC article.
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models.
Hoare O, Fraunhoffer N, Elkaoutari A, Gayet O, Bigonnet M, Roques J, Nicolle R, McGuckin C, Forraz N, Sohier E, Tonon L, Wajda P, Boyault S, Attignon V, Tabone-Eglinger S, Barbier S, Mignard C, Duchamp O, Iovanna J, Dusetti NJ. Hoare O, et al. Among authors: barbier s. Cancers (Basel). 2021 May 19;13(10):2473. doi: 10.3390/cancers13102473. Cancers (Basel). 2021. PMID: 34069519 Free PMC article.
67 results